Table 3

Prevalence of quality indicators among typology models

Prevalence of quality indicator (N reflects the number eligible for the outcome)Exclusively primary careFamily physician-dominant co-managementSpecialist-dominant co-managementExclusively specialist careLow engagement
N=6094N=1349N=4118N=707N=1149
Cancer screening outcomes
 Colorectal cancer screening (N=2829)478 (42.2%)125 (48.1%)306 (33.1%)24 (16.2%)12 (3.3%)
 Cervical cancer screening (N=2323)421 (50.9%)66 (45.8%)464 (46.0%)57 (33.7%)33 (18.9%)
 Mammography (N=591)139 (55.4%)26 (63.4%)112 (48.7%)10 (32.3%)4 (10.5%)
Health services delivery outcomes
 Any emergency department visits1815 (29.8%)483 (35.8%)1452 (35.3%)221 (31.3%)122 (10.6%)
 Any low-acuity emergency department visits876 (14.4%)233 (17.3%)714 (17.3%)119 (16.8%)70 (6.1%)
 Any hospital admissions470 (7.7%)226 (16.8%)479 (11.6%)82 (11.6%)33 (2.9%)
 Any HIV-specific hospital admissions57 (0.9%)76 (5.6%)121 (2.9%)25 (3.5%)≤5
 Number of specialist types seen ≥23630 (59.6%)1024 (75.9%)2712 (65.9%)395 (55.9%)150 (13.1%)
HIV-specific outcome
 Any receipt of ART among ODB eligible patients(N=8302)2271 (66.1%)866 (85.7%)2683 (86.6%)467 (87.3%)72 (32.3%)
  • ART, antiretroviral therapy; ODB, Ontario Drug Benefits.